TORRENT PHARMACEUTICALS
|
The Current P/B Ratio of TORRENT PHARMACEUTICALS is 15.59.
Share Price | ₹3,159.4 | Nov 07,2024 |
Market Cap | ₹106,914.1 Cr | |
Book Value | ₹6,856.2 Cr | Mar2024 - Consolidated Results |
Price/Book | 15.59x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of TORRENT PHARMACEUTICALS
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹106,914.1 Cr] as on Nov 07,2024
(/) Book Value [ ₹6,856.2 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 15.59x ]
Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay '15.59 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of TORRENT PHARMACEUTICALS !
The chart below summarizes the trend in P/B Ratio of TORRENT PHARMACEUTICALS over the last five years.
Historical PB (Price/Book ) ratio chart of TORRENT PHARMACEUTICALS
PB Ratio Performance Analysis for TORRENT PHARMACEUTICALS
- TORRENT PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.70x.
- TORRENT PHARMACEUTICALS 's operated at median p/b ratio of 7.95x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/b ratio peaked in Mar2024 at 12.84x.
- TORRENT PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2020 of 6.92x.
How does TORRENT PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
TORRENT PHARMACEUTICALS | 6,856.15 | 15.59 | 106,914.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.75 | 429,841.0 |
CIPLA LTD | 26,619.90 | 4.77 | 127,063.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.82 | 107,398.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.94 | 97,866.3 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.66 | 158,179.0 |
MANKIND PHARMA LTD | 9,339.84 | 11.70 | 109,234.0 |
LUPIN LTD | 14,175.80 | 6.79 | 96,282.2 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.63 | 78,437.3 |
ABBOTT INDIA LTD | 3,658.73 | 16.43 | 60,116.9 |
ALKEM LABORATORIES LTD | 10,292.50 | 6.65 | 68,407.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs TORRENT PHARMACEUTICALS 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.63x |
Max industry PB | 16.43x |
Median industry PB | 6.75x |
Average industry PB | 8.34x |
You may also like the below Video Courses